Literature DB >> 29982384

Using the consolidated framework for implementation research to understand safety net health system efforts to increase colorectal cancer screening rates.

Michelle C Kegler1, Derrick D Beasley1, Shuting Liang1, Megan Cotter1, Emily Phillips1, April Hermstad1, Rentonia Williams2, Jeremy Martinez2, Kara Riehman2.   

Abstract

Guided by the Consolidated Framework for Implementation Research (CFIR), this study aimed to identify factors that influence implementation of evidence-based provider and client-oriented strategies to promote colorectal cancer (CRC) screening in safety net health systems. Site visits and key informant interviews (n=33) were conducted with project leaders and staff in five health systems funded by an American Cancer Society grants program. Within- and cross-site analyses identified CFIR constructs that influenced implementation of provider and client-oriented strategies to promote CRC screening through colonoscopies and fecal immunochemical tests. Of the five CFIR domains, constructs within four CFIR domains (inner setting, outer setting, individual characteristics and process domains) were particularly salient in discussions of implementation while constructs within one CFIR domain (characteristics of the intervention) were not. This study provides a detailed description of how facilitating and inhibiting factors influenced the implementation of evidence-based practices related to CRC screening within safety net health systems. These findings can inform future efforts to promote evidence-based strategies to increase CRC screening rates in safety net health systems.

Entities:  

Mesh:

Year:  2018        PMID: 29982384     DOI: 10.1093/her/cyy019

Source DB:  PubMed          Journal:  Health Educ Res        ISSN: 0268-1153


  7 in total

1.  Assessing Levels and Correlates of Implementation of Evidence-Based Approaches for Colorectal Cancer Screening: A Cross-Sectional Study With Federally Qualified Health Centers.

Authors:  Timothy J Walker; Betsy Risendal; Michelle C Kegler; Daniela B Friedman; Bryan J Weiner; Rebecca S Williams; Shin-Ping Tu; Maria E Fernandez
Journal:  Health Educ Behav       Date:  2018-07-10

2.  Anal cancer screening among women with HIV: provider experiences and system-level challenges.

Authors:  Robin T Higashi; Serena A Rodriguez; Andrea C Betts; Jasmin A Tiro; Amneris E Luque; Rachel Rivera; Arti Barnes
Journal:  AIDS Care       Date:  2021-02-17

3.  Facilitators and barriers to implement the family doctor contracting services in China: findings from a qualitative study.

Authors:  Shasha Yuan; Fang Wang; Xi Li; Meng Jia; Miaomiao Tian
Journal:  BMJ Open       Date:  2019-10-08       Impact factor: 2.692

4.  Efficacy of intestinal obstruction stent combined with laparoscopic surgery and neoadjuvant chemotherapy in patients with obstructive colorectal cancer.

Authors:  Leilei Yang; Weiwei Ma; Meizhen Wang; Ruili Zhang; Tienan Bi; Shenkang Zhou
Journal:  Oncol Lett       Date:  2019-06-24       Impact factor: 2.967

5.  Clinicians and individuals with acquired brain injury perspectives about factors that influence mobility: creating a core set of mobility domains among individuals with acquired brain injury.

Authors:  Rehab Alhasani; Dennis Radman; Claudine Auger; Anouk Lamontagne; Sara Ahmed
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

6.  Clinicians' perceptions of barriers to cervical cancer screening for women living with behavioral health conditions: a focus group study.

Authors:  Rahma S Mkuu; Stephanie A Staras; Sarah M Szurek; Dalila D'Ingeo; Mary A Gerend; Dianne L Goede; Elizabeth A Shenkman
Journal:  BMC Cancer       Date:  2022-03-09       Impact factor: 4.430

7.  A Multilevel Approach to Understand the Context and Potential Solutions for Low Colorectal Cancer (CRC) Screening Rates in Rural Appalachia Clinics.

Authors:  Jamie Zoellner; Kathleen Porter; Esther Thatcher; Erin Kennedy; James L Werth; Betsy Grossman; Tomas Roatsey; Heather Hamilton; Roger Anderson; Wendy Cohn
Journal:  J Rural Health       Date:  2020-10-07       Impact factor: 5.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.